Pharmacy
Iowa Total Care adheres to the State of Iowa Preferred Drug List (PDL) to determine medications that are covered under the Iowa Total Care Pharmacy Benefit, as well as which medications may require Prior Authorization (PA).
Some members may have copayment or cost share when utilizing their prescription benefits. Please refer to the Iowa Total Care Member ID card for information or call Iowa Total Care at 1-833-404-1061.
For pharmacists only: For point-of-sale billing issues, please call 1-833-750-4405.
- Acute Migraine Treatments (PDF)
- ACL Inhibitors (PDF)
- Age Edit Override – Codeine or Tramadol (PDF)
- Alpelisib (Vijoice) (PDF)
- Alpha1 Proteinase Inhibitors (PDF)
- Alpha2 Agonist, Extended Release (PDF)
- Amylino Mimetic (Symlin®) (PDF)
- Antidepressants (PDF)
- Anti-Diabetic Non-Insulin Agents (PDF)
- Antiemetic-5HT3 Receptor Antagonists/Substance P Neurokinin Products (PDF)
- Antifungal Drugs - Oral / Injectable (PDF)
- Antihistamines (PDF)
- Apremilast-Otezla (PDF)
- Aripiprazole (Abilify MyCite) Tablets with Sensor (PDF)
- Baclofen (PDF)
- Becaplermin (Regranex®) (PDF)
- Benzodiazepines (PDF)
- Binge Eating Disorder Agents (PDF)
- Biologicals for Arthritis (PDF)
- Biologicals for Axial Spondyloarthritis (PDF)
- Biologicals for Hidradenitis Suppurativa (PDF)
- Biologicals for Inflammatory Bowel Disease (PDF)
- Biologicals for Plaque Psoriasis (PDF)
- Calcifediol (Rayaldee) (PDF)
- Cholic Acid (Cholbam®) (PDF)
- CNS Stimulants and Atomoxetine (PDF)
- Crisaborole (Eucrisa) (PDF)
- Cyclosporine Ophthalmic Emulsion (Verkazia) (PDF)
- Cystic Fibrosis Agents: Oral (PDF)
- Dalfampridine (Ampyra) (PDF)
- Deferasirox (PDF)
- Deflazacort (Emflaza) (PDF)
- Deucravacitinib (Sotyktu) (PDF)
- Dextromethorphan and Quinidine (Nuedexta) (PDF)
- Direct Oral Anticoagulants (PDF)
- Dojolvi (Triheptanoin) (PDF)
- Dupilumab (Dupixent) (PDF)
- Duplicate Therapy Edit Override (PDF)
- Eluxadoline (Viberzi™) (PDF)
- Erythropoiesis Stimulating Agents (PDF)
- Extended Release Formulations (PDF)
- Febuxostat (Uloric®) (PDF)
- Fentanyl, Short-Acting Products (PDF)
- Fifteen Day Initial Prescription Supply Override (PDF)
- Finerenone (Kerendia) (PDF)
- GLP-1 Agonist/Basal Insulin Combinations (PDF)
- Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist (PDF)
- Granulocyte Colony Stimulating Factor (PDF)
- Growth Hormones (PDF)
- Hemotopoietics/Chronic ITP (PDF)
- Hepatitis C Treatments (PDF)
- High Dose Opioids (PDF)
- IL-5 Antagonists (PDF)
- Initial Days' Supply Limit Override (PDF)
- Isotretinoin (Oral) (PDF)
- Janus Kinase (JAK) Inhibitors (PDF)
- Ketorolac Tromethamine (PDF)
- Lesinurad (Zurampic) (PDF)
- Letermovir (Prevymis™) (PDF)
- Lidocaine Patch (PDF)
- Linezolid (Zyvox®) (PDF)
- Long-acting Opioids (PDF)
- Lupron Depot - Adult (PDF)
- Lupron Depot - Pediatric (PDF)
- Mannitol Inhalation Powder (Bronchitol)
- Maralixibat (Livmarli) (PDF)
- Mavacamten (Camzyos) (PDF)
- Methotrexate Injection (PDF)
- Miconazole-Zinc Oxide-White Petrolatum (Vusion) Ointment (PDF)
- Mifepristone (Korlym®) (PDF)
- Miscellaneous (PDF)
- Modified Formulations (PDF)
- Multiple Sclerosis Agents: Oral (PDF)
- Muscle Relaxants (PDF)
- Naloxone Nasal Spray (PDF)
- Narcotic Agonist / Antagonist Nasal Sprays (PDF)
- Nebivolol (Bystolic®) (PDF)
- New-to-Market Drugs (PDF)
- Nocturnal Polyuria Treatments (PDF)
- Non-Parenteral Vasopressin Derivatives of Posterior Pituitary Hormone Products (PDF)
- Non-Preferred Drug (PDF)
- Nonsteroidal Anti-Inflammatory Drugs (PDF)
- Odevixibat (Bylvay) (PDF)
- Omalizumab (Xolair) (PDF)
- Opthalmic Agents for Presbyopia (PDF)
- Ospemifene (Osphena) (PDF)
- Oral Constipation Agents (PDF)
- Oral Glucocorticoids Duchenne Muscular Dystrophy (PDF)
- Oral Immunotherapy (PDF)
- Palivizumab (Synagis®) (PDF)
- PCSK9 Inhibitors (PDF)
- Peanut Allergen Powder - DNFP (Palforzia) (PDF)
- Pegcetacoplan (Empaveli) (PDF)
- Pirfenidone & Nintedanib (PDF)
- Potassium Binders (PDF)
- Proton Pump Inhibitors (PDF)
- Pulmonary Arterial Hypertension Agents (PDF)
- Quantity Limit Override (PDF)
- Repository Corticotropin Injection (H.P. Acthar Gel) (PDF)
- Rifaximin (Xifaxan®) (PDF)
- Risdiplam (Evrysdi)
- Roflumilast (Daliresp™) (PDF)
- Sapropterin Dihydrochloride (Kuvan) (PDF)
- Satralizumab (Enspryng) (PDF)
- Sedative/Hypnotics: Non-Benzodiazepine (PDF)
- Select Anticonvulsants (PDF)
- Select Non-Biologic Agents for Ulcerative Colitis (PDF)
- Select Preventative Migraine Treatments (PDF)
- Selected Brand Name Drugs (PDF)
- Select Oncology Agents (PDF)
- Select Topical Psoriasis Agents (PDF)
- Short-Acting Opioids (PDF)
- Sodium Oxybate (Xyrem®) (PDF)
- Tasimelteon (Hetlioz®) (PDF)
- Testosterone Products (PDF)
- Tezepelumab-ekko (Tezspire) (PDF)
- Topical Acne and Rosacea Products (PDF)
- Topical Antifungals for Onychomycosis (PDF)
- Topical Corticosteroids (PDF)
- Topical Immunomodulators (PDF)
- Tralokinumab-Idrm (Adbry) (PDF)
- Valsartan/Sacubitril (Entresto) (PDF)
- Vitamins & Minerals (PDF)
- Vericiguat (Verquvo) (PDF)
- Vesicular Monoamine Transporter (VMAT) 2 Inhibitors (PDF)
- Viloxazine (Qelbree) (PDF)
- Vorapaxar (Zontivity™) (PDF)
- Voxelotor (Oxbryta) (PDF)
Submit your prior authorization (PA) requests electronically through CoverMyMeds.
Electronic prior authorization (ePA) automates the PA process, making it simpler to complete PA requests. The ePA process is HIPAA-compliant and enables faster determinations.
For select drugs and plans, CoverMyMeds may issue immediate approval of your request and update your patient record to allow immediate claim adjudication.
To find a pharmacy that is in the Iowa Total Care network, you can use the Find a Provider tool.
Iowa Total Care members will have an option to receive a 90-day supply of certain maintenance medications. This encourages members to maintain healthy behaviors and decreases barriers to access. Please consider prescribing accordingly for members that would benefit from this allowance.
For the current list of 90-day supply allowance prescriptions, visit the Iowa Medicaid PDL page.